NEW YORK (GenomeWeb News) – Genedata and Bayer Schering Pharma have entered into a multi-year collaboration to develop and use Genedata's Biologics Data Platform at Bayer Schering locations, the companies said today.

Under the agreement, BDP will support biologics data management and analysis at Bayer Schering R&D sites in Europe and the US, which are developing protein-based therapeutics for diseases such as cancer, hemophilia, and multiple sclerosis.

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.